| Mr Andreas Joseph Bitterlich, PA-C | |
|
505 S 336th St, Suite 600, Federal Way, WA 98003-5947 | |
| (253) 838-6180 | |
| Not Available |
| Full Name | Mr Andreas Joseph Bitterlich |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 505 S 336th St, Federal Way, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043561749 | NPI | - | NPPES |
| 2022674 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA60309659 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Andreas Joseph Bitterlich, PA-C 505 S 336th St, Suite 600, Federal Way, WA 98003-5947 Ph: (253) 838-6180 | Mr Andreas Joseph Bitterlich, PA-C 505 S 336th St, Suite 600, Federal Way, WA 98003-5947 Ph: (253) 838-6180 |
News Archive
A novel drug proven to reduce the risk of disease progression by 79% as well as three new European Centres of Excellence, offer new hope to patients with inoperable metastatic advanced midgut neuroendocrine cancer.
SHIFT Communications, the leader in data-driven public relations and communications, today announced the expansion of its healthcare practice. Since January, SHIFT's healthcare practice has grown its revenue nearly 30 percent and expanded not only the team, but the diversity of the clientele they serve – moving beyond health information technology (IT) to sectors ranging from digital health to the life sciences.
A new long-term study finds over 20 years, only one in five women who have mammograms every two years will have to undergo follow up evaluation for a false positive finding. Only one in 16 will have an unnecessary invasive procedure over two decades.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company specializing in products for cancer and supportive care, announced today that it will present data from the ongoing work involving its lead product, MuGard, and host an oral mucositis symposium at the MASCC conference being held in Vancouver, B.C. on June 24-26, 2010. MuGard is Access Pharma's FDA-approved product for the management of oral mucositis, a debilitating side effect of many anticancer treatments.
› Verified 8 days ago
Aimee Edmunds, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 34509 9th Ave S Ste 204, Federal Way, WA 98003 Phone: 253-835-5510 Fax: 253-835-5511 | |
Katherine R Redmon, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400 | |
Kelsey Anne Van Every, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 34509 9th Ave S Ste 304, Federal Way, WA 98003 Phone: 253-939-1230 Fax: 360-874-5959 | |
Charlotte Duvall, PA-S Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 33915 1st Way S Ste 200, Federal Way, WA 98003 Phone: 253-838-9839 | |
John Mark Gaudino, P.A.-C. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1300 S 320th St, Federal Way, WA 98003 Phone: 253-839-2727 | |
Olesya Mykulyn, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 31405 18th Ave S, Federal Way, WA 98003 Phone: 253-681-6600 |